NCT01321879 2019-12-27Study to Evaluate the Safety and Efficacy of Telavancin in the Treatment of Gram Positive Bloodstream Infections in Cancer PatientsM.D. Anderson Cancer CenterPhase 2 Completed40 enrolled 6 charts